Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of inhaled SNG001 for virus-associated asthma worsening
2009-017480-42Phase 2Completed
- Sponsor
- Synairgen
- Start
- Mar 2010
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma and Respiratory viral illness comparing SNG001 with Placebo (2 arms). Started Mar 2010; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
asthmaRespiratory viral illness
Beyond the preview
Go deeper on 2009-017480-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017480-42.